BCBS Kansas City Medical Policy Updates – December 2018

Click here to view the Blue Cross Blue Shield Kansas City Medical Policy Updates »

December 2018 BCBS Kansas City Medical Policy Updates:

• Harvoni (sofosbuvir-ledipasvir)
• Immune Prophylaxis for Respiratory Syncytial Virus (RSV)
• Intravenous Anesthetics for the Treatment of Chronic Pain
• Kevzara (sarilumab)
•  Radicava (edaravone)
•  Cellular Immunotherapy for Prostate Cancer
•  Krystexxa (pegloticase)
•  Nerlynx (neratinib)
•  Nplate (romiplostim)
•  Ocaliva (obeticholic acid)
•  Overactive Bladder (OAB) Step Therapy Program
•  Rituxan Hycela (rituximab and hyaluronidase)
•  Siliq (brodalumab)
•  Tremfya (guselkumab)
•  Tymlos (abaloparatide)
•  Vosevi (sofosbuvir-velpatasvir-voxilaprevir)
•  Increlex (mecasermin)
•  Injectable Clostridial Collagenase for Fibroproliferative Disorders
•  Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease
•  Remicade (infliximab) Inflectra (infliximab-dyyb) Renflexis (infliximab-abda)
•  Simponi (golimumab)
• Microprocessor Controlled Prostheses for the Lower Limb
• Myoelectric Prosthetic Components for the Upper Limb
• Tumor Treating Fields Therapy
• BRAF Gene Variant Testing To Select Melanoma Patients
• Circulating Tumor DNA for Management of Non-Small-Cell Lung Cancer Liquid Biopsy
• Epidural Steroid Injections for Back Pain
• Immune Cell Function Assay
• Multitarget Polymerase Chain Reaction Testing for Diagnosis of Bacterial Vaginosis
• Nerve Fiber Density Measurement
• Percutaneous Left Atrial Appendage Closure Devices
• Pharmacogenomic and Metabolite Markers for  Patients Treated with Thiopurines 6MP
• Proteomic Testing for Systemic Therapy in Non Small Cell
• Quantitative Assay Measurement HER2 Total Protein Expression HER2 Dimers
• Testing Serum VitaminTesting
• Transanal Radiofrequency Treatment of Fecal Incontinence
• Urinary Biomarkers for Cancer Screening Diagnosis Surveillance
• Use of Common Genetic Variants to Predict Risk of Nonfamilial Breast Cancer
• Wearable Cardioverter Defibrillators
• Whole Exome Whole Genome Sequencing Diagnosis Genetic Disorders
• Reproductive Techniques
• Ultrasound in Pregnancy
• Dopamine Transporter Imaging With Single Photo Emission CT
• Vertebral Fracture Assessment with Densitometry
• Adipose-Derived Stem Cells in Autologous Fat Grafting to Breast
• Artificial Intervertebral Disc of the Lumbar Spine
• Bariatric Surgery
• Computer Assisted Navigation Orthopedic Procedure
• Discectomy
• Implantable Sinus Stents for Postoperative Use Following Endoscopic Sinus Surgery
• Magnetic Resonance Guided Focused Ultrasound
• Placental and Umbilical Cord Blood asSource of Stem Cells
• Total Artificial Hearts and Implantable Ventricular Assist Devices
• Adoptive Immunotherapy
• Hematopoietic Stem Cell Transplantation for Miscellaneous Solid Tumors in Adults

Click here to view the Blue Cross Blue Shield Kansas City Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.